Linezolid
Linezolid is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Linezolid; Generic name: LINEZOLID; Drug class: Oxazolidinone Antibacterial [EPC].
| Brand name | Linezolid |
|---|---|
| Generic name | LINEZOLID |
| Drug class | Oxazolidinone Antibacterial [EPC] |
| Manufacturer | Hikma Pharmaceuticals USA Inc. |
| Used for | 1 INDICATIONS AND USAGE Linezolid for Oral Suspension is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria: Nosocomial pneumonia ( 1.1 ); Community-acquired pneumonia ( 1. 2); Complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis ( 1. 3); Uncomplicated skin and skin structure infections ( 1. 4); Vancomycin-resistant Enterococcus faecium infections. ( 1. 5) Limitations of Use ( 1.6 ): • Linezolid is not indicated for the treatment of Gram-negative infections. • The safety and efficacy of linezolid formulations given for |
| Dosage | 2 DOSAGE AND ADMINISTRATION Dosage, Route, and Frequency of Administration Infection Pediatric Patients (Birth through 11 years of age) Adults and Adolescents (12 years and older) Duration (Days) Nosocomial pneumonia Community-acquired pneumonia, including concurrent bacteremia 10 mg/kg intravenous or oral every 8 hours 600 mg intravenous or oral every 12 hours 10 to 14 Complicated skin and skin structure infections Vancomycin-resistant Enterococcus faecium infections, including concurrent bacte |
| Active ingredient(s) | LINEZOLID |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16007ca5-7956-4414-af38-406a6623400e |